Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
Block & Leviton LLP Investigates MAP Pharmaceuticals, Inc., for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Allergan, Inc.

BOSTON, Jan. 23, 2013 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a Boston-based law firm representing investors nationwide, has commenced an investigation into possible breaches of fiduciary duty by the Board of Directors of MAP Pharmaceuticals, Inc. ("MAP" or the "Company") (NASDAQ:  MAPP) concerning the proposed acquisition of the Company by Allergan, Inc. ("Allergan") in an all cash tender offer expected to close late in the first quarter or in the second quarter of 2013.

Under the terms of the proposed merger, Allergan will acquire MAP in a deal for approximately $25.00 per MAP share, setting a value for MAP at approximately $958 million.  The Company's stock price has been on a steady upward climb over the past two months, gaining approximately 20 percent since receiving positive drug development news in mid-November 2012.  The proposed tender offer share price fails to take into account the fact that MAP's common stock is set to soar upon the anticipated approval of its new migraine treatment LEVADEX.  Indeed, no potential acquirer would have had the highly detailed knowledge of MAP as Allergan, MAP's partner in the development of Levadex.  As such, it appears that the proposed transaction premium offers insufficient recognition of MAP's growth potential.  Analyst Carl Cachia, writing for the website Seeking Alpha, placed a price target of $30 for MAP stock by the end of 2013.

Block & Leviton's investigation seeks to determine, among other things, whether MAP's Directors breached their fiduciary duties by failing to maximize shareholder value in the proposed acquisition by Allergan and the overall fairness of the process by which the MAP Directors considered and approved the transaction.

If you are a MAP shareholder and have questions about your legal rights, or if you have information relevant to this investigation, please contact attorney Steven P. Harte, at
(617) 398-5600 or email him at Steven@blockesq.com.  

Block & Leviton is a Boston-based law firm representing investors nationwide for violations of securities laws.  The firm's lawyers have collectively been prosecuting securities cases on behalf of investors for over 50 years.  This notice may constitute attorney advertising.

Contact:
BLOCK & LEVITON LLP
Steven P. Harte, Esq.
steven@blockesq.com 
(617) 398-5600

SOURCE Block & Leviton LLP

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
Internet of @ThingsExpo Silicon View billboards on Highway 101 are seen by 1.3 million motorists per week. Internet of @ThingsExpo announces that its Call for Papers is now open. Topics include all aspects of providing or using massively scalable IT-related capabilities as a serv...
Bluetooth® innovator CSR plc (LSE: CSR; NASDAQ: CSRE) announced the launch of its CSRmesh™ Development Kit, which will allow developers to get hands on with the recently launched CSRmesh Bluetooth Smart protocol. The kit, which became available from selected CSR distributors in J...
The theme of this year's CODE_n Contest is the Internet of Things (IoT), a nascent, future-facing development of the Internet wherein objects and systems are embedded with computing power and are able to communicate with each other. The contest seeks the most exciting founders an...
Many mid-market companies have invested significant time and resources to secure and back up their servers, client computers, data, and overall network infrastructure in what was the traditional client-server setup. Now, what were considered emerging technologies just a few years...
Recent high profile security breaches at major online websites tell us static passwords are not the answer. Even recent SMS security additions to consumer websites do little to address the issue. Fortunately, a more secure authentication system is available for consumer websites...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE

Breaking Cloud Computing News

SAN JOSE, Calif., Aug. 1, 2014 /PRNewswire/ -- Atmel® Corporation (Nasdaq: ATML), a global leader...